EFG Asset Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
PCM
AAM
WCMNY
PWAM
EFG Asset Management's AMED Position: Q3 2023 in Review
EFG Asset Management sold out of Amedisys (AMED) in Q3 2023, closing a stake of 10,915 shares — an estimated $998K sold.
EFG Asset Management first reported a position in AMED in Q1 2022 and held it in 6 quarters. The position peaked at $1.2M in Q1 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.
- EFG Asset Management reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
- EFG Asset Management sold 10,915 Amedisys shares in Q3 2023, an estimated $998K.
- EFG Asset Management first reported a position in Amedisys in Q1 2022 and held it in 6 quarters.
- EFG Asset Management's Amedisys position peaked at $1.2M in Q1 2022.
- 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.
Based on EFG Asset Management's 13F filing for Q3 2023, filed 2 Nov 2023.